Key Record Dates Identifier: NCT02907177
Brief Title: Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®) (POINT)

First Submitted : August 25, 2016
First Submitted that Met QC Criteria : September 15, 2016
First Posted : September 20, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : April 3, 2020
Last Update Posted : April 6, 2020